Sebastian E Schneider

6PUBLICATIONS
32CO-AUTHORS
Molecular targetsMolecular medicineToxicology (incl. clinical toxicology)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 20, 2026
Discovery of Potent 1,3-Cyclobutane-Containing Dual A2A/A2B Receptor Antagonists with Low Projected Human Dose for the Treatment of Cancer.

|May 05, 2026
Discovery of MK-1088 as a Potent A2A/A2B Adenosine Receptor Dual-Antagonist for Cancer Immunotherapy.

|Apr 29, 2026
Discovery of Potent and Selective Benzothiophene Difluoromethyl Phosphonate (DFMP) PTPN2/N1-Dual Inhibitors.

|Feb 12, 2026
Discovery and In Vivo Evaluation of Aryl Ether YAP1/TEAD Inhibitors for the Treatment of Hippo-Driven Malignancies.

Brandon A Vara, Jongwon Lim, Casey J Moure

|Mar 23, 2021
Development of a Flexible and Robust Synthesis of Tetrahydrofuro[3,4-b]furan Nucleoside Analogues.

David A Candito, Yingchun Ye, Ryan V Quiroz

|Mar 23, 2021
The Discovery of Two Novel Classes of 5,5-Bicyclic Nucleoside-Derived PRMT5 Inhibitors for the Treatment of Cancer.

Ryan V Quiroz, Michael H Reutershan, Sebastian E Schneider

Pageof 1

Frequent Collaborators

3 joint publications

Charles S Yeung

3 joint publications

Duane E DeMong

2 joint publications

Ryan V Quiroz

2 joint publications

Lorena Rico